Advanced Medical Optics: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Abbott Medical Optics Inc.
Type subsidiary
Founded Santa Ana, California (2002)
Headquarters Santa Ana, California
Key people James V. Mazzo Chairman, President and CEO
Industry Ophthalmology
Products Ophthalmic pharmaceuticals
Surgical equipment
Contact care products
Employees 3,800 (2007)
Parent Abbott Laboratories
Website http://www.amo-inc.com/

Abbott Medical Optics Inc. earlier known as Advanced Medical Optics, Inc. (Also known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO is based in Santa Ana, California, and employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.

Contents

History

AMO (originally American Medical Optics) started business in 1976 as a pioneer in the early development of intraocular lenses for cataract patients.
AMO was spun off from Allergan in 2002.
AMO bought Irvine-based IntraLase Corp. for $808 million in January 2007. This allowed AMO to combine IntraLase technology for cutting a flap in the cornea with AMO technology for reshaping the cornea. The combination of these complementary technologies has made “all-laser LASIK” possible.[1] NASA later approved this all-laser LASIK for use on astronauts.[2]
In August 2007 the company donated $2.5 million to UC-Irvine’s Department of Ophthalmology to boost the university’s planned Eye Institute. [2]
In February 2009 Abbott completed its acquisition of Advanced Medical Optics [3]

Voluntary recalls

AMO voluntarily recalled some of their products in 2006 due to a bacterial contamination in the factory process which would have compromised sterility. Non-sterility of a contact lens solution may have serious health consequences, including eye infection and microbial keratitis. The voluntary and limited recall was caused by an isolated production line problem that affected two of the four production lines in the AMO facility, not because of a formulation issue.[4] This happened in the midst of a recall scare period caused by Bausch & Lomb's worldwide product recall, after eye care doctors in Singapore traced 90% of their patients' eye infections, some to the serious extent of causing blindness, to B&L products. In fact, no reports of adverse health effects due to the suspected-affected batch of products were made to AMO. In some countries, there were initial confusion between B&L's product dangers and AMO's voluntary recall.

In May 2007, the Centers for Disease Control and Prevention linked AMO MoisturePlus eye solution to Acanthamoeba keratitis infections.[5] AMO announced a recall on Complete MoisturePlus contact lens solution on May 28th, 2007. [1] The solution has been linked to cases of an eye infection (keratitis) caused by an organism of the genus Acanthamoeba. [2] The Company was sued in June 2007 by Michael Connolly, who claimed to have developed a keratitis infection after using AMO's MoisturePlus solution.[6] [7]

On June 20, 2009 The Associated Press published an article titled, "Contact Solution Maker Failed to Report Problems." The article states, Complaints about a contact lens solution linked to a 2007 outbreak of eye infections that blinded several people went unreported by the manufacturer for more than a year, government documents show. The documents show Advanced Medical Optics received complaints about the solution more than a year before it was recalled, and failed to promptly report nine complaints as required by law.[8]

There are still many on-going class action lawsutis against AMO, comprised of those claiming the non-sterile contact lense solution has caused injury and complete blindness in some cases. [9]

Consumer products

Advertisements

All-in-one Systems for soft contact lenses

  • COMPLETE Blink-N-Clean Lens Drops

Hydration Solutions

  • Blink Contacts 10ml
  • Blink Contacts 20*0.35ml
  • Blink Eyedrops 10ml
  • Blink Eyedrops 20*0.35ml

Systems for formstabile, permiable contact lenses

  • Totalcare All-in-One
  • Totalcare Solution
  • Totalcare Cleaner
  • Totalcare Tablets
  • Totalcare Lens case

Protein Removers

  • Ultrazyme Tablets

Multipurpose Solutions

  • COMPLETE Moisture PLUS Lubricating and Rewetting Drops

Peroxide Systems

  • Oxysept 1 Step 1 Month
  • Oxysept 1 Step 3 Months
  • Oxysept 1 Step 6 Months
  • Oxysept 1 Step Tablets
  • Oxysept 1 Step Lens case
  • UltraCare Disinfecting Solution/Neutralizer
  • Ultrazyme Enzymatic Cleaner

Surgical Products

Abbott acquisition of Advanced Medical Optics

  • On February 26, 2009 Abbott announced that it has completed its acquisition of Advanced Medical Optics (AMO).
  • AMO is now a wholly owned subsidiary of Abbott and has been renamed Abbott Medical Optics Inc.

References

Whitestar Signature with Fusion Fluidics

External links


Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message